Flow cytometric analysis after 6 d of treatment showed that IRE1α inhibition increased tumor infiltration by cytotoxic CD8+ T cells and their expression of the activation markers IFN-γ, PD-1, and CD69, independent of IRE1α status in the malignant cells (Fig. 6 E). The gene discussed is ERN1; the disease is neoplasm.